Related Experiment Video
Updated: May 5, 2026
05:52
Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
Published on: June 30, 2011
19.3K
The discovery of insulin: the Rochester, New York, connection
Ralph Madeb1, Leonidas G Koniaris, Seymour I Schwartz
1University of Rochester Medical Center, Rochester, New York, USA. ralph_madeb@urmc.rochester.edu
Annals of Internal Medicine
|December 21, 2005
Summary
Insulin therapy revolutionized diabetes treatment. Early U.S. patient records reveal insulin
Area of Science:
- Endocrinology
- Metabolic Diseases
- Medical History
Background:
- The landmark discovery of insulin by Dr. Frederick G. Banting in Toronto is widely recognized.
- The introduction and early application of insulin therapy in the United States remain less documented.
- Rochester, New York, a city with a nascent medical school, was the site of the first U.S. insulin treatment.
Observation:
- A series of historical letters details the medical journey of a young diabetes patient.
- The patient's condition was documented before and after the implementation of insulin therapy.
Findings:
- Insulin therapy marked a significant turning point in managing juvenile diabetes.
- The patient's clinical course demonstrated a dramatic improvement following insulin administration.
Implications:
- This case study highlights the critical role of early insulin adoption in the United States.
- The successful treatment underscores the transformative impact of insulin on diabetes patient outcomes.
- Understanding historical patient experiences provides valuable context for contemporary diabetes care.
More Related Videos
Related Concept Videos
01:05Insulin Secretory Vesicles
6.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.8K
01:28Insulin: The Receptor and Signaling Pathways
6.0K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
2.1K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
2.1K
01:16Insulin: Dosing Regimen and Adverse Effects
1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
01:26Diabetes Mellitus: Introduction
56
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
56